This informational white paper is part of a compendium intended to share best practices and ongoing learnings related to the impact of COVID-19 on ongoing and planned clinical trials. Content is authored by a dedicated team of experienced scientists, clinicians, technologists, and data quality experts.

To read other white papers in the series, please visit

Download White Paper